←Back to Expert Scholars
Translational Medicine / 转化医学Glioblastoma Immunotherapy
David Reardon
MD
🏢Dana-Farber Cancer Institute🌐USA
Clinical Director, Center for Neuro-Oncology
105
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
David Reardon led CheckMate-143 and related trials evaluating nivolumab in recurrent glioblastoma. He has shaped neuro-oncology immunotherapy research and clinical development at Dana-Farber and the broader international neuro-oncology community.
Share:
🧪Research Fields 研究领域
glioblastoma
CheckMate-143
nivolumab glioma
neuro-oncology trials
brain tumor immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 David Reardon 的研究动态
Follow David Reardon's research updates
留下邮箱，当我们发布与 David Reardon（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment